Dulaglutide Treatment Reduces Glycemic Excursions in People with Type 2 Diabetes: A Post-hoc Analysis of Six Phase 3 Randomized Clinical Trials

被引：0
|
作者：
Charpentier, Guillaume
Garcia-Perez, Luis E.
Thieu, Vivian T.
Jia, Nan
Jacobson, Jennie G.
Pechtner, Valeria
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2388-PUB
引用
收藏
页码：A623 / A623
页数：1
相关论文
共 50 条
  • [1] Dulaglutide treatment reduces glycaemic excursions in people with type 2 diabetes: a post-hoc analysis of 6 phase 3 randomised clinical trials
    Pechtner, V.
    Charpentier, G.
    Garcia-Perez, L. -E.
    Thieu, V. T.
    Jia, N.
    Jacobson, J. G.
    [J]. DIABETOLOGIA, 2017, 60 : S386 - S386
  • [2] Dulaglutide decreases liver enzymes in people with type 2 diabetes: a post-hoc analysis of the AWARD programme
    Haupt, A.
    Cusi, K.
    Sattar, N.
    Garcia-Perez, L. -E.
    Pavo, I.
    Yu, M.
    Robertson, K. E.
    [J]. DIABETOLOGIA, 2017, 60 : S574 - S575
  • [3] Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial
    Qifu Li
    Qiqi Zhang
    Rui Wang
    Tianpei Hong
    [J]. Diabetes Therapy, 2022, 13 : 161 - 173
  • [4] Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial
    Li, Qifu
    Zhang, Qiqi
    Wang, Rui
    Hong, Tianpei
    [J]. DIABETES THERAPY, 2022, 13 (01) : 161 - 173
  • [5] Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
    Asger Wretlind
    Viktor Rotbain Curovic
    Andressa de Zawadzki
    Tommi Suvitaival
    Jin Xu
    Emilie Hein Zobel
    Bernt Johan von Scholten
    Rasmus Sejersten Ripa
    Andreas Kjaer
    Tine Willum Hansen
    Tina Vilsbøll
    Henrik Vestergaard
    Peter Rossing
    Cristina Legido-Quigley
    [J]. Lipids in Health and Disease, 22
  • [6] Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials
    Wretlind, Asger
    Curovic, Viktor Rotbain
    de Zawadzki, Andressa
    Suvitaival, Tommi
    Xu, Jin
    Zobel, Emilie Hein
    von Scholten, Bernt Johan
    Ripa, Rasmus Sejersten
    Kjaer, Andreas
    Hansen, Tine Willum
    Vilsboll, Tina
    Vestergaard, Henrik
    Rossing, Peter
    Legido-Quigley, Cristina
    [J]. LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [7] Effect of Retatrutide on Kidney Parameters in People with Type 2 Diabetes and/or Obesity-A Post-Hoc Analysis of Two Phase 2 Trials
    Heerspink, Hiddo L.
    Lu, Zeqing
    Du, Yu
    Duffin, Kevin L.
    Coskun, Tamer
    Haupt, Axel
    Hartman, Mark L.
    [J]. DIABETES, 2024, 73
  • [8] Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
    Gallo, Silvina
    Calle, Roberto A.
    Terra, Steven G.
    Pong, Annpey
    Tarasenko, Lisa
    Raji, Annaswamy
    [J]. DIABETES THERAPY, 2020, 11 (08) : 1849 - 1860
  • [9] Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
    Silvina Gallo
    Roberto A. Calle
    Steven G. Terra
    Annpey Pong
    Lisa Tarasenko
    Annaswamy Raji
    [J]. Diabetes Therapy, 2020, 11 : 1849 - 1860
  • [10] Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis
    Patel, Hiren
    Munir, Kashif
    Sutherland, Sindee
    Karanikas, Chrisanthi A.
    Konig, Manige
    [J]. DIABETES THERAPY, 2019, 10 (06) : 2321 - 2330
12345